RNA silencing drugs
These companies make drugs that silence or adjust genes by targeting RNA, such as siRNA and antisense medicines.
−54.5%
over 1 year · S&P 500 +11.6%
Key indicators
Health
47 / 100
Fragile
Solid
Up over 1 year
3 of 11
Volatility
70%
Calm
Choppy
Profitability
−229%
Low
High
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 13 companies
ALNY
−63.5%
ARWR
+15.4%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
A
Alnylam Pharmaceuticals
ALNY
55.2%
−63.5%
A
Arrowhead Pharmaceuticals
ARWR
16.9%
+15.4%
I
Ionis Pharmaceuticals
IONS
12.1%
−60.0%
S
Sarepta Therapeutics
SRPT
4.9%
−10.7%
S
Stoke Therapeutics
STOK
4.4%
+6.2%
A
ADARx Pharmaceuticals
ADRX
3.8%
W
Wave Life Sciences
WVE
1.5%
−55.0%
T
Entrada Therapeutics
TRDA
0.5%
−36.5%
K
Korro Bio
KRRO
0.5%
−56.7%
P
PepGen
PEPG
0.4%
−15.0%
A
Arbutus Biopharma
ABUS
−15.5%
C
City Therapeutics
CTY
S
Silence Therapeutics
SLN
+194.7%